Toby Ferguson - Aug 18, 2025 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: Chief Medical Officer
Signature: /s/ Robin Swartz, as Attorney-in-Fact for Toby Ferguson
Stock symbol: VYGR
Transactions as of: Aug 18, 2025
Transactions value $: -$70,870
Form type: 4
Date filed: 8/20/2025, 02:09 PM
Previous filing: Apr 4, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ferguson Toby	Chief Medical Officer	C/O VOYAGER THERAPEUTICS, INC., 75 HAYDEN AVENUE, LEXINGTON	/s/ Robin Swartz, as Attorney-in-Fact for Toby Ferguson	2025-08-20	0002015616

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Sale	-$70.9K	-19K	-12.03%	$3.73	139K	Aug 18, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.